Brookfield Property Partners along with ArrowMark Partners and Conversion Venture Capital’s $86 million acquisition of minority stakes in Convene

Jones Day has advised Brookfield Property Partners in its $86 million acquisition along with ArrowMark Partners and Conversion Venture Capital, of minority stakes in Convene. Brookfield...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Pieris Pharmaceuticals and AstraZeneca Strike up to $2.1 Billion Collaboration on Anticalin-based Inhaled Treatments for Respiratory Diseases

Goodwin represented Pieris Pharmaceuticals in its strategic collaboration with AstraZeneca to develop novel inhaled drugs that leverage Pieris’ Anticalin® platform. AstraZeneca will make an upfront and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here